📰 Given Aptose Bioscience News
Given Aptose Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Aptose Bioscience. Real-time updates on events, politics, business and more.
March 11, 2024
Cabaletta Bio (NASDAQ:CABA – Get Free Report) and Aptose Biosciences (NASDAQ:APTO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Volatility and Risk Cabaletta Bio has a […]
March 11, 2024
Cabaletta Bio (NASDAQ:CABA – Get Free Report) and Aptose Biosciences (NASDAQ:APTO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership. Analyst Recommendations This is a breakdown of […]
February 25, 2024
Aptose Biosciences (NASDAQ:APTO – Get Free Report) and Sutro Biopharma (NASDAQ:STRO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Risk & Volatility Aptose Biosciences has a […]
April 5, 2023
Aptose Biosciences (NASDAQ:APTO – Get Rating) and Quince Therapeutics (NASDAQ:QNCX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, earnings and profitability. Analyst Recommendations This is a breakdown of recent ratings […]
March 29, 2023
Aptose Biosciences (NASDAQ:APTO – Get Rating) and Quince Therapeutics (NASDAQ:QNCX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Volatility and Risk Aptose Biosciences has a beta of […]
June 1, 2022
Aptose Biosciences (NASDAQ:APTO – Get Rating) and Caribou Biosciences (NASDAQ:CRBU – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Institutional and Insider Ownership 34.2% of Aptose Biosciences shares […]